Top compounds associated with response to ASB6


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.09
mRNA BX-912 GDSC1000 pan-cancer AAC 0.05 0.09
mRNA Doxorubicin gCSI pan-cancer AAC 0.091 0.09
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA GDC-0941 GDSC1000 pan-cancer AAC 0.056 0.1
mRNA Nilotinib CCLE pan-cancer AAC -0.083 0.1
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.065 0.1
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.062 0.1
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.086 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.1
Download CSV